Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Bisphenol A Safety

Research results may call into question conclusions of a federal report

by Bette Hileman
February 4, 2008 | A version of this story appeared in Volume 86, Issue 5

Studies with baby mice show that multiple modes of exposure to BPA are of concern.
[+]Enlarge
Credit: Shutterstock
Credit: Shutterstock

A STUDY conducted by researchers at the University of Missouri, Columbia, strikes at the heart of a federal panel's conclusions about the health concerns of bisphenol A (BPA)—the high-production-volume chemical used to make polycarbonate plastic (Repro. Tox. DOI:10.1016/j.reprotox.2008.01.001), say experts in the field.

Last August, a panel appointed by the National Toxicology Program's Center for the Evaluation of Risks to Human Reproduction (CERHR) reported that it had "some concern" that prenatal exposure to BPA causes neural and behavioral defects in infants and children, and "minimal" or "no concern" about any other health effects. It reached these conclusions by considering only those studies in which lab animals had been exposed orally to BPA and disregarding all experiments in which the animals had been injected or given the compound subcutaneously.

Biologist Frederick S. vom Saal and colleagues at Missouri disagreed strongly with the CERHR conclusions because fetuses and newborns lack, or express at very low levels, the liver enzyme needed to deactivate BPA, in contrast to adults who metabolize it quickly. This fact, the researchers argue, indicates that exposure by any means will affect fetuses and newborns.

To test this theory, vom Saal separated three-day-old mice into four groups. Two groups were exposed to oral doses of BPA. The other two groups were injected with BPA. Blood measurements of biologically active BPA over the next 24 hours showed that the route of administration made no difference, vom Saal says.

"Vom Saal's study is a very important piece of work," Gail S. Prins, a professor of physiology at the University of Illinois, Chicago, says. It could invalidate the CERHR panel's conclusions, she adds.

"Our research shows that the decision by the CERHR panel is without merit and unsupported by the scientific literature," vom Saal says.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.